Stay updated on Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FWYZUD1fGfs6XxjMrGAbcvS03Xsk.uncropped.jpg&w=3840&q=75)
Latest updates to the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 31 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.2%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.0%
- Check32 days agoChange DetectedThe value on the web page has changed from 'Show more Revision: v2.9.0' to 'MedlinePlus Genetics related topics: Lung cancer MedlinePlus related topics: Lung Cancer Drug Information available for: Nivolumab FDA Drug and Device Resources'. This indicates an update in the information displayed on the page related to genetics topics, drug information, and FDA resources.SummaryDifference22%
Stay in the know with updates to Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Switch vs Delayed Nivolumab in Squamous NSCLC Clinical Trial page.